Therapeutic Experience of Saxagliptin as First Add-on after Metformin in Indian Type 2 Diabetes Patients: A Non-interventional, Prospective, Observational Study (ONTARGET-INDIA)

INTRODUCTION: Dipeptidyl peptidase 4 (DPP4) inhibitors are widely used in type 2 diabetes mellitus (T2DM) patients but the data available in existing clinical trial programmes on DPP4 inhibitors include limited number of patients from India. Hence, this study attempted to understand usage, efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalra, Sanjay, Bajaj, Sarita, Unnikrishnan, A. G., Baruah, Manash P., Sahay, Rakesh, Hardik, V., Kumar, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683677/
https://www.ncbi.nlm.nih.gov/pubmed/31641633
http://dx.doi.org/10.4103/ijem.IJEM_56_19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6683677/
https://www.ncbi.nlm.nih.gov/pubmed/31641633
http://dx.doi.org/10.4103/ijem.IJEM_56_19

Ejemplares similares